Table 1.
Age (years) | 59.1 ± 8.56 |
---|---|
BMI (kg/m2) | 30.6 ± 4.42 |
Education (years) | 10.2 ± 3.8 |
Cancer diagnosis onset (months) | 84.7 ± 38.9 |
Lymphedema duration (months) | 49.8 ± 35.1 |
Lymphedema severity (moderate/severe) | 9/18 |
Affected side (R/L) | 11/16 |
Dominant/non-dominant involvement | |
Dominant side, n (%) | 11 (40.7) |
Non-dominant side, n (%) | 16 (59.3) |
Radiotherapy (yes), n (%) | 25 (92.6) |
Radiotherapy duration (n) | 25 (25–28) |
Chemotherapy (yes), n (%) | 24 (88.9) |
Chemotherapy (number of cycles) | 6 (4–6) |
Type of operation | |
Lumpectomy + ALND | 6 |
Radical mastectomy + ALND | 5 |
Modified radical mastectomy + ALND | 11 |
Breast conserving surgery + ALND | 5 |
Removed lymph nodes (n) | 21.4 ± 7.6 |
Data are presented as mean ± standard deviation or number (%) or median (interquartile range)
BMI body mass index, ALND axillary lymph node dissection